Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02042378 |
Title | A Study of Rucaparib in Patients With Pancreatic Cancer and a Known Deleterious BRCA Mutation |
Recruitment | Completed |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Clovis Oncology, Inc. |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA | ISR |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Cedars Sinai Medical Center | Los Angeles | California | 90048 | United States | Details | |
Mayo Clinic | Rochester | Minnesota | 55902 | United States | Details | |
New York University | New York | New York | 10012 | United States | Details | |
University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | United States | Details | |
MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
Rambam Healthcare Campus | Haifa | 31096 | Israel | Details | ||
Hadassah Hebrew University Hospital (Sharett Institute of Oncology) | Jerusalem | 91120 | Israel | Details | ||
Tel Aviv Sourasky Medical Center | Tel Aviv | 64239 | Israel | Details |